MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 99 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $328,000 | +420.6% | 3,364 | +503.9% | 0.02% | +150.0% |
| Q4 2018 | $63,000 | -47.5% | 557 | -0.9% | 0.01% | -33.3% |
| Q3 2018 | $120,000 | -99.9% | 562 | +28.9% | 0.01% | -18.2% |
| Q2 2018 | $121,944,000 | +937930.8% | 436 | +296.4% | 0.01% | +1000.0% |
| Q1 2018 | $13,000 | +30.0% | 110 | +2.8% | 0.00% | 0.0% |
| Q4 2017 | $10,000 | +900.0% | 107 | +529.4% | 0.00% | – |
| Q3 2017 | $1,000 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |